RNS Number : 2602N
NetScientific PLC
15 May 2015


NetScientific plc

("NetScientific" or the "Group")


Capital Markets Day



London, UK - 15 May 2015 - NetScientific plc (AIM: NSCI), the biomedical and healthcare technology group, is holding a Capital Markets Day for institutional investors and analysts today in London.


The event includes a presentation on NetScientific's refined strategy which has been under review since the full year results in March. In summary, the strategy is to fund, develop and manage early and mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the USA and UK. The primary focus will remain on digital health, diagnostics and therapeutics. These sectors represent highly attractive growth markets where breakthrough technology solutions are in high demand. The Group will be concentrating on its five lead companies and further strengthening its strategic relationships with partners such as Breakout Labs, to build a unique transformative portfolio. 

There will also be presentations from key companies in the portfolio. A copy of the presentations from the day will be made available on the website:

No new information will be disclosed during the Capital Markets Day.




About NetScientific


NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net. 



Contact Details



Peter Thoms, CFO

Tel: +44 (0)77 2055 5752


Gary Clarence / Daniel Adams

Tel: +44 (0)20 7597 4000

Instinctif Partners

Melanie Toyne-Sewell / Jayne Crook

Tel: +44 (0)20 7457 2020 Email: netscientific@instinctif.com



This information is provided by RNS
The company news service from the London Stock Exchange